PhaseBio Pharmaceuticals, Inc. (PHAS): Price and Financial Metrics


PhaseBio Pharmaceuticals, Inc. (PHAS)

Today's Latest Price: $3.91 USD

0.26 (7.12%)

Updated Nov 13 8:00pm

Add PHAS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

PHAS Daily Price Range
PHAS 52-Week Price Range

PHAS Stock Price Chart More Charts


PHAS Price/Volume Stats

Current price $3.91
Prev. close $3.65
Day low $3.61
Day high $3.91
50-day MA $4.37
200-day MA $7.91
52-week high $16.65
52-week low $2.55
Volume 179,000
Avg. volume 292,535
Dividend yield N/A
Market Cap 112.21M

PhaseBio Pharmaceuticals, Inc. (PHAS) Company Bio


PhaseBio Pharmaceuticals, Inc. engages in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.





PHAS Latest News Stream


Event/Time News Detail
Loading, please wait...

PHAS Latest Social Stream


Loading social stream, please wait...

View Full PHAS Social Stream

PHAS Price Returns

1-mo -1.01%
3-mo -45.01%
6-mo -63.63%
1-year -4.40%
3-year N/A
5-year N/A
YTD 26.54%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4615 seconds.